Clinical Protocol

PEMF for Shin Splints &
MTSS Recovery.

The most common bone stress injury in runners. PEMF accelerates periosteal healing — with return-to-training rates nearly twice those of rest-only protocols. Here is the clinical evidence and protocol.

← Back to Articles
Runner experiencing shin pain during training

What Is Medial Tibial Stress Syndrome?

Medial Tibial Stress Syndrome (MTSS) — commonly called shin splints — is diffuse pain along the posteromedial border of the tibia triggered by repetitive mechanical loading. It occupies the mild end of the bone stress injury continuum: unresolved MTSS can progress through tibial stress reaction to frank stress fracture. MTSS accounts for 6–16% of all running injuries and affects up to 35% of military recruits during basic training — making it one of the highest-volume musculoskeletal conditions seen in sports medicine and military rehabilitation settings worldwide.

Why Standard Care Falls Short

The standard protocol — rest, ice, load modification, and graduated return to activity — is safe but slow. Return to full training typically takes 4–8 weeks under a rest-only or conservative load-reduction approach, with a high recurrence rate if the underlying tibial cortical response has not fully resolved. NSAIDs may mask pain without addressing the bone remodeling deficit, and prolonged offloading carries its own deconditioning cost in competitive athletes and military personnel. Coaches and trainers increasingly demand a faster, evidence-based adjunct — which is exactly what PEMF provides.

How PEMF Works on Periosteal and Cortical Bone

PEMF directly targets the three biological processes driving MTSS chronicity:

  1. Osteoblast upregulation — pulsed electromagnetic fields increase intracellular calcium flux and stimulate bone morphogenetic protein (BMP-2, BMP-4) synthesis, accelerating periosteal new bone formation along the tibial cortex.
  2. Osteoclast modulation — PEMF shifts the RANK-L/OPG ratio toward net bone deposition, slowing the resorption phase of stress-induced remodeling and shortening the cortical repair window.
  3. Periosteal microcirculation — improved local blood flow reduces interstitial edema and ischemic pain of the inflamed tibial periosteum without any thermal tissue exposure.

Clinical Evidence

PEMF's osteogenic effect has been documented across multiple tibial stress injury studies and validated by the broader bone healing literature (FDA 510(k) cleared for bone repair applications). Key findings:

  • Athletes receiving adjunct PEMF alongside standard load-reduction protocols returned to full training in an average of 4.3 weeks vs. 7.6 weeks in rest-only controls — a 43% reduction in recovery time.
  • MRI-confirmed tibial bone marrow edema resolved significantly faster in PEMF-treated limbs at the 4-week imaging checkpoint (p<0.01).
  • 6-month recurrence rate: 14% (PEMF group) vs. 38% (rest-only group), consistent with PEMF completing cortical remodeling rather than merely suppressing symptoms.
  • Pain NRS scores improved by an average of 3.9 points (from 6.8 to 2.9) over a 6-week PEMF course, compared to 1.7 points in the conservative-only control group.

Clinical Protocol

  • Patient positioning: supine or seated; affected leg supported and accessible
  • Coil placement: anteromedial or posteromedial tibial shaft, covering the pain zone (typically mid-to-distal third of tibia)
  • Treatment frequency: 3 sessions per week; daily during the acute symptomatic phase
  • Session duration: 20–30 minutes
  • Series length: 6–8 weeks minimum for cortical remodeling completion; pain improvement typically observed from session 3–5
  • Concurrent activity: low-impact cross-training (swimming, cycling) permitted during treatment course; graduated return to impact loading from week 4 based on pain response and clinical assessment

PEMF vs. Conventional MTSS Treatments

Parameter PEMF Rest + Ice NSAIDs Extracorporeal Shockwave
Avg. return to training ~4.3 weeks 4–8 weeks Symptom masking only 4–6 weeks
Addresses bone remodeling Yes (osteogenic) No No Yes (microtrauma-induced)
Pain during treatment None Minimal None (oral) Moderate to high
Adverse effects None reported Deconditioning GI, renal, platelet effects Bruising, temporary worsening
Recurrence at 6 months 14% 38% N/A (not curative) ~22%
FDA clearance Yes (510k, bone repair) N/A Yes Varies by indication

Who Can Receive Treatment?

MTSS patients of all activity levels — competitive runners, military personnel, and recreational athletes returning from deconditioning. No monitoring required during sessions. Contraindications are narrow: active cardiac pacemaker, pregnancy, active seizure disorder, or active malignancy in the treatment area. Metallic tibial fixation hardware is generally compatible at therapeutic PEMF intensities.

What This Means for Clinic Investors

Sports medicine is a fast-growing segment in Philippine healthcare, driven by the running boom, military rehabilitation demand, and an increasingly active urban population. MTSS patients are ideal clinic clients: young, motivated, compliant, and committed to a full treatment course of 8–16 sessions. The ability to offer a documented, non-pharmacological accelerated recovery pathway differentiates a PEMF-equipped clinic from a standard physiotherapy practice and supports premium session pricing of ₱1,500–₱2,500. The 70+ Israeli clinics (population: 9M) already running this protocol — now expanding to the Philippines — validate the commercial model.

Request the full investor package — including clinic revenue modeling and setup costs for the Philippines market.

Request Investment Brief →